Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of EndoClot™ Spraying After Endoscopic Resection of Large Colorectal Polyps

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a ≥20mm colon non-pedunculated polyp who are undergoing an ESD or EMR resection~* signed Informed Consent~Exclusion Criteria:~* Patients with known (biopsy proven) or strongly suspected invasive carcinoma in a potential study polyp~* Pedunculated polyps (as defined by Paris Classification type Ip or Isp)~* ulcerated depressed lesions (as defined by Paris Classification type III)~* polyposis syndromes~* inflammatory bowel disease~* emergency colonoscopy~* Poor general health (ASA (American Society of Anaesthesiologists) class\>3)~* Patients with coagulopathy with an elevated International Normalized Ratio (INR )≥1.5, or platelets \<50~* Poor bowel preparation~* pregnancy or breastfeeding~* Intervention planned using ORISE™ (Boston Medical) or LIFTUP™ (Ovesco) as lifting agents

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- EndoClot group (Type: ACTIVE_COMPARATOR): patients who are being provided with EndoClot adhesive spray after polyp resection
- Control group (Type: SHAM_COMPARATOR): no further prophylactic bleeding prevention after polyp resection

Based on this trial design, predict the completion outcome and termination type (if applicable).